TruAlt Bioenergy Q1 FY27 Earnings Call Transcript Released
TruAlt Bioenergy Limited released its Q1 FY27 earnings call transcript. The company reported Q1 FY27 revenue of ₹626.90 crore and PAT of ₹59.3 crore. The CBG business generated ₹11 crore revenue and ₹4-4.5 crore PAT. SAF business is progressing with ₹150 crore viability gap funding secured. New CBG plants are expected to be operational by Q3/Q4 FY27.
The announcement includes detailed financial results, updates on new business initiatives (CBG, SAF), and secured funding, which are material to investors.
The company reported strong financial performance with significant year-on-year growth in revenue and profit, alongside progress in key business verticals like CBG and SAF, and secured government funding.
TruAlt Bioenergy Limited has released the transcript of its Earnings Conference Call held on July 29, 2026, to discuss the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
During the quarter, the company reported significant improvements in revenue and profitability. The Managing Director, Mr. Vijaykumar Murugesh Nirani, highlighted the successful conversion of three units to dual feed plants, leading to increased ethanol production and sales. The company produced and sold approximately 8.5 crore litres of ethanol, generating revenue of around ₹630 crore. The Chief Financial Officer, Mr. Anand Kishore, detailed the financial performance, with the ethanol segment achieving a top line of ₹626.90 crore and an EBITDA of ₹147.3 crore. Profit Before Tax (PBT) stood at ₹78.4 crore, and Profit After Tax (PAT) was ₹59.3 crore, marking a substantial year-on-year increase.
The company also provided updates on its Compressed Biogas (CBG) business, reporting a revenue of approximately ₹11 crore and a PAT of ₹4-4.5 crore with a 40-45% margin. Construction is nearing completion for three out of four planned CBG plants under a JV with Sumitomo, expected to be operational by Q3 FY27, with revenues starting in Q4 FY27. A second JV with GAIL is progressing with land acquisition for six more plants, anticipated to add 72 tons per day capacity from Q4 FY27.
In the Sustainable Aviation Fuel (SAF) business, front-end engineering works are in advanced stages, with EPC quotations to be invited soon. The company secured ₹150 crore in viability gap funding from the Government of India under the PM JI-VAN Yojana.
The fuel retail business is experiencing growth opportunities with the adoption of flex-fuel vehicles. The company has established seven outlets and plans to commission four more by the end of the current quarter. Discussions are ongoing with airlines and aircraft manufacturers for potential SAF collaborations.
What to do with a filing like this
TruAlt Bioenergy Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by TruAlt Bioenergy Limited. Read the original for the full detail.